Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Treasury Shares (2020 - 2025)

Journey Medical's Treasury Shares history spans 6 years, with the latest figure at $1.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 21.02% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Dec 2025, down 21.02%, and an annual FY2025 reading of $1.8 million, down 21.02% over the prior year.
  • Treasury Shares for Q4 2025 was $1.8 million at Journey Medical, down from $1.9 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.7 million in Q2 2024, with the low at $708524.0 in Q3 2021.
  • Average Treasury Shares over 5 years is $1.8 million, with a median of $1.9 million recorded in 2023.
  • Year-over-year, Treasury Shares surged 238.96% in 2022 and then crashed 43.13% in 2023.
  • Tracing DERM's Treasury Shares over 5 years: stood at $715030.0 in 2021, then soared by 216.22% to $2.3 million in 2022, then crashed by 42.2% to $1.3 million in 2023, then soared by 79.04% to $2.3 million in 2024, then dropped by 21.02% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Treasury Shares are $1.8 million (Q4 2025), $1.9 million (Q3 2025), and $2.4 million (Q2 2025).